Chiral isoindrone fused cyclic hexapeptide derivative and preparation method and application of derivative
A technology of isoindolinone and cyclic hexapeptide, which is applied in the field of synthetic medicinal chemistry and anti-tumor, can solve the problems of difficult extraction and separation of Phakellistatin6 cyclic peptide, and difficulty in meeting actual needs, and achieve simple reaction conditions, convenient operation, and good anti-tumor active effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
specific Embodiment approach 1
[0016] Specific embodiment 1: The chemical name of the chiral isoindolinocyclic hexapeptide derivative in this embodiment is 3-hydroxyl-isoindolinocyclic (glycyl-prolyl-L-leucyl-pro aminoacyl-L-isoleucyl-prolylbenzylamine), wherein the proline configuration is pure L-type or D-type, and its C-3 position is pure R-configuration or S-configuration, and the structural formula is :
[0017]
[0018] Wherein R&S means that the chirality of the carbon atom is R or S type.
[0019] The C-3 position described in this embodiment is a chiral carbon atom.
specific Embodiment approach 2
[0020] Specific embodiment two: the preparation method of the chiral isoindolinone cyclohexapeptide derivative in this embodiment is carried out according to the following steps:
[0021]1. ①Dissolve Boc-proline in solvent Ⅰ, condense with N-trimethylsilylbenzylamine under the catalysis of condensing agent Ⅰ, and then use trifluoroacetic acid to remove the Boc protection of the amino terminal to obtain intermediate product Ⅰ ; ② Dissolve Boc-L-isoleucine in solvent Ⅱ, condense with intermediate product Ⅰ under the catalysis of condensation agent Ⅱ, and then use trifluoroacetic acid to remove the Boc protection of the amino terminal to obtain intermediate product Ⅱ; ③ Boc-L- Dissolve proline in solvent III, condense with intermediate product II under the catalysis of condensation agent III, and then use trifluoroacetic acid to remove the Boc protection at the amino terminal to obtain intermediate product III; ④ Dissolve Boc-L-leucine in solvent In IV, condense with intermediate...
specific Embodiment approach 3
[0029] Embodiment 3: This embodiment is different from Embodiment 2 in that: the reaction temperature of the condensation described in step 1 ① to ⑤ is all 10-50° C. Others are the same as in the second embodiment.
PUM
| Property | Measurement | Unit |
|---|---|---|
| Ic50 | aaaaa | aaaaa |
| Ic50 | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
Login to View More 


